Warburg's Ruoxi Chen: Innovative therapies will drive demand for Simtra BioPharma Solutions

Warburg Pincus and Advent International earlier this week completed the carve-out of Baxter International’s BPS business for $4.25bn.

DealsFeaturedHealthcareIndustrialsManufacturingTop Stories